Teglicar chloride

Overview

Teglicar chloride (ST1326 chloride) is an orally active, reversible, mixed-type, selective inhibitor of hepatic carnitine palmitoyltransferase I ( L-CPT I ), with an IC 50 of 1.1 μM against rat L-CPT I. Teglicar chloride reduces serum glucose levels. Teglicar chloride exhibits antiketotic activity in normal fasted rats. Teglicar chloride can be used in research related to type 2 diabetes and ketoacidosis.

Application

Products | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Glucose Metabolism | Products > Disease Areas > Type 2 Diabetes | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Metabolic Disease | Products > Signaling Pathways > Carnitine Palmitoyltransferase (CPT) | Products > Signaling Pathways > Acyltransferase

Product Information

• Catalog No.: HY-182248
• CAS No.: 908566-80-3
• Molecular Formula: C22H46ClN3O3
• Molecular Weight: 436.07
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source